13F filing recap · Q4 2020

What did Brave Warrior Advisors buy in Q4 2020?

Reported stock-position changes between this filing and the previous one.

Stock value

$2.72B

Positions

Estimated turnover

9.5%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

Increased positions

AONAon Plc$316.40Mreported value+174.1K shares+13.2%ELVElevance Health, Inc.$247.60Mreported value+7.2K shares+0.9%CACCCredit Acceptance Corp$157.62Mreported value+313.6K shares+221.1%UNHUnitedHealth Group Incorporated$57.20Mreported value+3.2K shares+2.0%MCOMoody’s Corporation$952.0Kreported value+150 shares+4.8%

Reduced positions

BRK.BBerkshire Hathaway Inc$323.58Mreported value-57.1K shares-3.9%JPMJPMorgan Chase & Co$283.18Mreported value-16.6K shares-0.7%HCAHCA Healthcare, Inc.$266.78Mreported value-15.6K shares-1.0%PRIPrimerica, Inc.$223.66Mreported value-2.9K shares

Exited positions

CDKCdk Global, Inc.$342.0Kprior reported value-7.8K shares-100.0%